Showing results (3111-3120 of 9,925) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|August 12, 2009
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCTS O Ciurea, R Saliba, G Rondon, et al.Bone Marrow Transplantation|March 2, 2011
New developments in conditioning regimens before auto-SCT in multiple myelomaP Moreau, M Attal, J L HarousseauBone Marrow Transplantation|March 2, 2011
Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomasM Delioukina, J Zain, J M Palmer, et al.Bone Marrow Transplantation|March 2, 2011
Hematopoietic SCT for adult T-cell leukemia/lymphoma: a reviewM Jabbour, H Tuncer, J Castillo, et al.Bone Marrow Transplantation|March 2, 2011
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot studyC Schmid, M Schleuning, J Tischer, et al.Bone Marrow Transplantation|March 2, 2011
The EBMT activity survey 2009: trends over the past 5 yearsH Baldomero, M Gratwohl, A Gratwohl, et al.Bone Marrow Transplantation|March 2, 2011
Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphomaD G Stover, V K Reddy, Y Shyr, et al.Bone Marrow Transplantation|March 15, 2011
Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantationG Milone, M Poidomani, S Leotta, et al.Bone Marrow Transplantation|March 7, 1998
Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liverD C Fisher, J J Vredenburgh, W P Petros, et al.Bone Marrow Transplantation|March 7, 1998
Changes of telomere length in children after hematopoietic stem cell transplantationM Akiyama, Y Hoshi, S Sakurai, et al.Pageof 993